Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.
about
Remodeling of HDL remnants generated by scavenger receptor class B type IEvidence for differential effects of apoE3 and apoE4 on HDL metabolismHDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathwayEvaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteinsCommon variants at 30 loci contribute to polygenic dyslipidemiaThe role of the lymphatic system in cholesterol transportAdvances in the Study of the Antiatherogenic Function and Novel Therapies for HDLIdentification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levelsCathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid effluxMonocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levelsMonogenic dyslipidemias: window on determinants of plasma lipoprotein metabolismAbnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient miceA computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolismThe effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in miceEpidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.Genetic and nongenetic sources of variation in phospholipid transfer protein activityEnlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression.Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis.Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing mapsInteraction of phospholipid transfer protein with human tear fluid mucins.O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipidsPharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes.Niacin inhibits vascular inflammation via downregulating nuclear transcription factor-κB signaling pathway.Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1Infection and inflammation-induced proatherogenic changes of lipoproteins.Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.Impact of phospholipid transfer protein on nascent high-density lipoprotein formation and remodeling.Tangier disease as a test of the reverse cholesterol transport hypothesis.Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP).Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.High-density lipoprotein: gene-based approaches to the prevention of atherosclerosis.Proprotein convertases in high-density lipoprotein metabolism.Genetic determinants of plasma triglyceridesAn amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux.Effect of plasma phospholipid transfer protein deficiency on lethal endotoxemia in mice.Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: a mutation-inactivation study.Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions
P2860
Q24297431-B50696EC-ED52-4BA3-B9E1-DD8D52EC600BQ24313446-E822B0F8-1BE1-4B37-9E84-F223AA08A2D4Q24323992-92FEC5D0-A237-4C61-AADD-C5F1E692C3B3Q24533539-4C027E6F-8910-41ED-B2B9-0CB448EE12E5Q24598765-D9F666F2-41CC-4F86-8415-702F940FE378Q26782973-B0A42C2E-92A2-4A64-81B1-0C55654F4EA1Q26801507-A773CBBE-5825-4CF4-9506-A5BCBD812CBAQ28204853-1ED82DAE-5546-4BDB-91D4-1139530BE91BQ28267787-DD9A691F-480C-4637-8FE8-12E456F10039Q28363489-E758889D-FFD4-4083-9CED-519EB0572083Q28363810-CFCB78FE-A185-4A24-8630-945CE4B08EABQ28365792-31065E09-489D-42AA-99AB-AF56414E18DCQ28538300-F8F94253-2D79-4B06-B546-100B188A671AQ28594692-8E621432-D7B7-4CDC-9F58-70BE0369C0A1Q30239897-F540F9AC-B59E-4012-9554-121DA04F4FDAQ30494062-4629849C-0BB1-4504-A87B-811EA1E36F6CQ30979037-DF09F3B5-3F11-4A4E-8962-9A5C337119B0Q33338480-CB186614-0DCD-4F69-9060-1D23ABD1BF9FQ33577893-B912CCD1-A235-4086-99CC-8E34822C87C3Q33666024-569E76E3-8186-4F51-A5F4-1E4E2C8E7C58Q33691116-EAFDD155-D114-4B34-87E5-EF11198605C2Q33714941-3ACFDAAF-2E01-4ADF-A981-5CD661189F5DQ33758775-2E1106F6-654B-49BE-94EE-CB54CCCA4BEEQ33780365-334061F6-053A-4EAC-BDEB-EF097CFEF257Q33897743-05EBB8BB-E8A7-46A4-B8F7-A90EE80D7B86Q33935040-85AA8BB8-07B1-440E-A1B8-6E1BF9F03501Q33993200-7CE730C6-F6C0-4BFF-BB0D-2D984E242C0BQ34076399-37B5DAF6-5C4D-49A9-B498-578F81DF2194Q34086519-E67FD36B-B5E9-4AC9-8ADF-A2869655D673Q34114968-15F56658-A7EA-47BF-8C82-77288EFC0C5FQ34116322-62C072B6-23E3-4ABA-942D-09ACA32CF367Q34155049-61AB2009-F4E5-413F-AE68-E1CF4D8BC2FBQ34157567-7EF26B21-F257-47B1-B96F-ADFCF5FF4F9AQ34256139-4CC4D036-D718-411C-B9C2-6AE2DFDB8088Q34503333-B58C670D-9CE3-435A-AE3A-4CAC1E81CF3EQ34655812-5AA06C78-BC2A-48EA-8F58-8FEE7116C90DQ34656242-F4EFB3B7-DF6A-4FE2-A990-760B2F6BB750Q34656954-309DDAC2-32F1-40AB-81D7-45856F47522FQ34680124-B00B3C59-D3E4-46CE-B59E-60099F349978Q34740387-4E72FABE-95D5-41B9-9011-438DDB7AA408
P2860
Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Targeted mutation of plasma ph ...... gh-density lipoprotein levels.
@ast
Targeted mutation of plasma ph ...... gh-density lipoprotein levels.
@en
type
label
Targeted mutation of plasma ph ...... gh-density lipoprotein levels.
@ast
Targeted mutation of plasma ph ...... gh-density lipoprotein levels.
@en
prefLabel
Targeted mutation of plasma ph ...... gh-density lipoprotein levels.
@ast
Targeted mutation of plasma ph ...... gh-density lipoprotein levels.
@en
P2093
P2860
P356
P1476
Targeted mutation of plasma ph ...... gh-density lipoprotein levels.
@en
P2093
O L Francone
P2860
P304
P356
10.1172/JCI5578
P407
P577
1999-03-01T00:00:00Z